companydata.dkUnibio USA ApS: Financial statements 2021
CVR: 38179845
Unibio USA ApS (CVR 38179845) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -15,000 and a net result of DKK -12,000 compared with DKK -11,000 the year before. Equity amounted to DKK 72,000. The solvency ratio was 73.5%.
- Gross Profit
- -15,000 kr.
- Profit/Loss
- -12,000 kr.
- Equity
- 72,000 kr.
- Total Assets
- 98,000 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -15 t. | -12 t. | 72 t. | 0 |
| 2020 | - | -14 t. | -11 t. | 8 t. | 0 |
| 2019 | - | -15 t. | -12 t. | 19 t. | 0 |
| 2018 | - | -15 t. | -12 t. | 31 t. | 0 |
Find more companies like Unibio USA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Unibio USA ApS has published its annual report for 2020. Gross profit came to DKK -14,000, and the net result was DKK -11,000.
As of June 1, 2021, Søren Olrik Eklund is registered as adm. dir. of Unibio USA ApS.
As of May 31, 2021, Henrik Busch-Larsen has stepped down as adm. dir. of Unibio USA ApS.
About Unibio USA ApS
Unibio USA ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Søren Olrik Eklund and David Richard Henstrom. The company is owned by UNIBIO A/S. In 2025, the company reported a net result of DKK -20,000 compared with DKK -26,000 the year before. Equity amounted to DKK 25,000.